ADHD May Stem from Emotion Dysregulation, Not Just Attention Deficits

New research suggests that emotion dysregulation—not attention problems—is the core issue underlying ADHD. This shift in understanding explains why ADHD often co-occurs with anxiety, mood instability, and anger, as poor emotional control disrupts executive functioning. Treating the root cause may lead to more effective interventions for individuals with ADHD.
In October 2026, Dr. Carla Shuman published a clinical perspective in *From Trial to Triumph* asserting that emotion dysregulation—not attention deficits—is the core issue underlying ADHD, challenging long-standing diagnostic and treatment paradigms. This view is supported by research cited in Awais Aftab’s New York Times article, which highlights that children under 12 treated with medication show improvements in both attention and emotional regulation, with early intervention linked to enhanced frontal lobe development. The shift in understanding stems from decades of clinical observation and emerging evidence that emotional dyscontrol disrupts executive functioning—impairing focus, organization, task initiation, and working memory. This explains the high comorbidity of ADHD with anxiety, mood instability, and anger, conditions rooted in poor emotional regulation rather than attention alone. The article references existing treatment models where medication paired with therapy yields better outcomes, particularly for children in structured environments like schools. However, adult patients often discontinue medication post-schooling despite ongoing struggles with emotional control, suggesting a gap in long-term support systems.
The key players include clinicians like Dr. Shuman and researchers such as Aftab, who advocate for redefining ADHD’s root cause to prioritize emotion regulation. Mental health professionals are divided on treatment approaches: while some emphasize me
This reframing of ADHD could significantly influence clinical practice, public perception, and healthcare policy by shifting focus from symptom management to emotional regulation as a primary target. If widely adopted, it may lead to earlier interventions in children, improved treatment adherence, and reduced stigma around emotional outbursts often mislabeled as behavioral issues. Schools and workplaces might redesign accommodations to support emotional regulation rather than solely addressing attentional deficits. The mental health market could see growth in executive function coaching and emotion-focused therapies, while pharmaceutical companies may reposition ADHD medications as neurodevelopmental stabilizers rather than just stimulants. A comparable precedent is the shift in understanding autism spectrum disorder from a purely cognitive condition to one involving sensory and emotional regulation, which transformed support models. What may follow is increased demand for integrated c